title: Synergistic action between jasmonic acid and nitric oxide in inducing matrine accumulation of Sophora flavescens suspension cells.
abstract: Secondary metabolites not only play important ecological roles in plants but also are important pharmaceutical and source compounds for derivative synthesis. Production of plant secondary metabolites is believed to be controlled by the endogenous signal network of plants. However, the molecular basis is still largely unknown. Here we show that matrine production of Sophora flavescens Ait. cells treated with low levels of jasmonic acid (JA) and nitric oxide (NO) is significantly increased although treatment with low concentrations of JA or NO alone has no effects on matrine production, showing that JA and NO may act synergistically in triggering matrine production. Moreover, treatment with NO triggers lipoxygenase (LOX) activity and enhances JA levels of the cells, showing that NO may activate the endogenous JA biosynthesis of S. flavescens cells. External application of JA induces nitric oxide synthase-like activities and stimulates NO generation of S. flavescens cells, which suggests that JA may trigger NO generation of the cells. Thus, the results reveal a mutually amplifying reaction between JA and NO in S. flavescens cells. Furthermore, JA and NO inhibitors suppress not only the mutually amplifying reaction between JA and NO but also the synergistic effects of NO and JA on matrine production. Therefore, the data demonstrate that the synergistic action of JA and NO in inducing matrine production might be due to the mutually amplifying reaction between JA and NO in the cells.
authors.affiliation: Department of Biotechnology, Zhejiang Gongshang University, Hangzhou 310035, China. maojunxu@163.com
authors.forename: Mao-Jun
authors.initials: MJ
authors.lastname: Xu
authors.forename: Ju-Fang
authors.initials: JF
authors.lastname: Dong
mesh_terms: D000470:Alkaloids / Q000378:metabolism*; D003517:Cyclopentanes / Q000378:metabolism / Q000494:pharmacology*; D004357:Drug Synergism; D004789:Enzyme Activation / Q000187:drug effects; D008084:Lipoxygenase / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism*; D020030:Nitric Oxide Donors / Q000378:metabolism / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000378:metabolism; D009599:Nitroprusside / Q000378:metabolism / Q000494:pharmacology; D054883:Oxylipins / Q000378:metabolism / Q000494:pharmacology*; D011807:Quinolizines / Q000378:metabolism*; D029909:Sophora / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D000093842:Matrines
chemical_list: D000470:Alkaloids; D003517:Cyclopentanes; D020030:Nitric Oxide Donors; D054883:Oxylipins; D011807:Quinolizines; D009599:Nitroprusside; D009569:Nitric Oxide; C011006:jasmonic acid; D008084:Lipoxygenase; D019001:Nitric Oxide Synthase; D000093842:Matrines